Xconomy Boston

TargAnox Garners $5,100,000 Series A Funding Round

  • Feed Type
  • Date
    3/30/2009
  • Company Name
    TargAnox
  • Mailing Address
    101 Huntington Avenue, 4th Floor Boston, MA 02199
  • Company Description
    TargAnox is focused on developing drugs to curb a sometimes disease-related biochemical condition called oxidative stress.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,100,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Ascent Biomedical Ventures
  • Venture Investor
    Partners Innovation Fund
  • Venture Investor
    Partners HealthCare System

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.